1 116 146 A PILOT STUDY OF A YOGA MEDITATION PROTOCOL FOR PATIENTS WITH MEDICALLY REFRACTORY EPILEPSY. OBJECTIVE: THE OBJECTIVE WAS TO ASSESS THE EFFICACY OF A YOGA MEDITATION PROTOCOL (YMP) AS AN ADJUNCTIVE TREATMENT IN PATIENTS WITH DRUG-RESISTANT CHRONIC EPILEPSY. DESIGN: THE DESIGN WAS A PROSPECTIVE, NONRANDOMIZED, OPEN-LABEL, ADD-ON TRIAL WITH A 12-WEEK BASELINE PERIOD, FOLLOWED BY A 12-WEEK SUPERVISED YMP ADMINISTRATION PHASE. THE FREQUENCY OF COMPLEX PARTIAL SEIZURES (CPS) WAS ASSESSED AT 3, 6, AND 12 MONTHS OF THE TREATMENT PERIOD. SETTING: THE SETTING WAS A COMPREHENSIVE EPILEPSY CARE CENTER ATTACHED TO A TERTIARY REFERRAL MEDICAL INSTITUTION SITUATED ON THE SOUTHWEST COAST OF THE INDIAN PENINSULA. SUBJECTS: THE SUBJECTS WERE 20 PATIENTS (14 MALES AND 6 FEMALES, AGE RANGE 15 TO 47 YEARS, MEDIAN 27 YEARS) WITH UNEQUIVOCALLY ESTABLISHED DIAGNOSES OF EPILEPSY WITH AT LEAST 4 CPS (WITH OR WITHOUT SECONDARY GENERALIZATION) DURING THE PRECEDING 3 MONTHS. INTERVENTION: INTERVENTION CONSISTED OF A YMP 20 MINUTES TWICE DAILY (MORNINGS AND EVENINGS) AT HOME, AND SUPERVISED SESSIONS OF A YMP EVERY WEEK FOR 3 MONTHS. CONTINUATION OF THE YMP BEYOND 3 MONTHS WAS OPTIONAL. OUTCOME MEASURE: THE OUTCOME MEASURE WAS THE SEIZURE FREQUENCY AT 3, 6, AND 12 MONTHS OF THE TREATMENT PERIOD. THE SUBJECTS WITH > OR = 50% REDUCTION IN MONTHLY SEIZURE RATE FROM BASELINE WERE CLASSIFIED AS RESPONDERS, AND SUBJECTS WITH <50% SEIZURE REDUCTION AS NONRESPONDERS. RESULTS: AT 3 MONTHS, A REDUCTION IN SEIZURE FREQUENCY WAS NOTED IN ALL EXCEPT 1 PATIENT, SIX OF WHOM HAD > OR = 50% SEIZURE REDUCTION. OF 16 PATIENTS WHO CONTINUED THE YMP BEYOND 3 MONTHS, 14 PATIENTS RESPONDED AT 6 MONTHS; 6 OF THEM WERE SEIZURE-FREE FOR 3 MONTHS. ALL EIGHT PATIENTS WHO CONTINUED THE YMP BEYOND 6 MONTHS RESPONDED; THREE OF THEM WERE SEIZURE FREE FOR 6 MONTHS. CONCLUSIONS: IF CONFIRMED THROUGH RANDOMIZED TRIALS INVOLVING A LARGER NUMBER OF PATIENTS, THIS YMP MAY BECOME A COST-EFFECTIVE AND ADVERSE EFFECT-FREE ADJUNCTIVE TREATMENT IN PATIENTS WITH DRUG-RESISTANT EPILEPSIES. 2006 2 260 44 ACCEPTANCE AND COMMITMENT THERAPY AND YOGA FOR DRUG-REFRACTORY EPILEPSY: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: THERE IS A NEED FOR CONTROLLED OUTCOME STUDIES ON BEHAVIORAL TREATMENT OF EPILEPSY. THE PURPOSE OF THIS STUDY WAS TO EVALUATE ACCEPTANCE AND COMMITMENT THERAPY (ACT) AND YOGA IN THE TREATMENT OF EPILEPSY. METHODS: THE DESIGN CONSISTED OF A RANDOMIZED CONTROLLED TRIAL WITH REPEATED MEASURES (N=18). ALL PARTICIPANTS HAD AN EEG-VERIFIED EPILEPSY DIAGNOSIS WITH DRUG-REFRACTORY SEIZURES. PARTICIPANTS WERE RANDOMIZED INTO ONE OF TWO GROUPS: ACT OR YOGA. THERAPEUTIC EFFECTS WERE MEASURED USING SEIZURE INDEX (FREQUENCY X DURATION) AND QUALITY OF LIFE (SATISFACTION WITH LIFE SCALE, WHOQOL-BREF). THE TREATMENT PROTOCOLS CONSISTED OF 12 HOURS OF PROFESSIONAL THERAPY DISTRIBUTED IN TWO INDIVIDUAL SESSIONS, TWO GROUP SESSIONS DURING A 5-WEEK PERIOD, AND BOOSTER SESSIONS AT 6 AND 12 MONTHS POSTTREATMENT. SEIZURE INDEX WAS CONTINUOUSLY ASSESSED DURING THE 3-MONTH BASELINE AND 12-MONTH FOLLOW-UP. QUALITY OF LIFE WAS MEASURED AFTER TREATMENT AND AT THE 6-MONTH AND 1-YEAR FOLLOW-UPS. RESULTS: THE RESULTS INDICATE THAT BOTH ACT AND YOGA SIGNIFICANTLY REDUCE SEIZURE INDEX AND INCREASE QUALITY OF LIFE OVER TIME. ACT REDUCED SEIZURE INDEX SIGNIFICANTLY MORE AS COMPARED WITH YOGA. PARTICIPANTS IN BOTH THE ACT AND YOGA GROUPS IMPROVED THEIR QUALITY OF LIFE SIGNIFICANTLY AS MEASURED BY ONE OF TWO QUALITY-OF-LIFE INSTRUMENTS. THE ACT GROUP INCREASED THEIR QUALITY OF LIFE SIGNIFICANTLY AS COMPARED WITH THE YOGA GROUP AS MEASURED BY THE WHOQOL-BREF, AND THE YOGA GROUP INCREASED THEIR QUALITY OF LIFE SIGNIFICANTLY AS COMPARED WITH THE ACT GROUP AS MEASURED BY THE SWLS. CONCLUSIONS: THE RESULTS OF THIS STUDY SUGGEST THAT COMPLEMENTARY TREATMENTS, SUCH AS ACT AND YOGA, DECREASE SEIZURE INDEX AND INCREASE QUALITY OF LIFE. 2008 3 1637 25 MODULATION OF CARDIAC AUTONOMIC BALANCE WITH ADJUVANT YOGA THERAPY IN PATIENTS WITH REFRACTORY EPILEPSY. THE PRACTICE OF YOGA REGULATES BODY PHYSIOLOGY THROUGH CONTROL OF POSTURE, BREATHING, AND MEDITATION. EFFECTS OF YOGA ON AUTONOMIC FUNCTIONS OF PATIENTS WITH REFRACTORY EPILEPSY, AS QUANTIFIED BY STANDARDIZED AUTONOMIC FUNCTION TESTS (AFTS), WERE DETERMINED. THE YOGA GROUP (N=18) RECEIVED SUPERVISED TRAINING IN YOGA, AND THE EXERCISE GROUP (N=16) PRACTICED SIMPLE ROUTINE EXERCISES. AFTS WERE REPEATED AFTER 10 WEEKS OF DAILY SESSIONS. DATA WERE COMPARED WITH THOSE OF HEALTHY VOLUNTEERS (N=142). THE YOGA GROUP SHOWED SIGNIFICANT IMPROVEMENT IN PARASYMPATHETIC PARAMETERS AND A DECREASE IN SEIZURE FREQUENCY SCORES. THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE PARAMETERS IN EITHER GROUP. TWO PATIENTS IN THE YOGA GROUP ACHIEVED NORMAL AUTONOMIC FUNCTIONS AT THE END OF 10 WEEKS OF THERAPY, WHEREAS THERE WERE NO CHANGES IN THE EXERCISE GROUP. THE DATA SUGGEST THAT YOGA MAY HAVE A ROLE AS AN ADJUVANT THERAPY IN THE MANAGEMENT OF AUTONOMIC DYSFUNCTION IN PATIENTS WITH REFRACTORY EPILEPSY. 2008 4 2664 41 YOGA IN CHILDREN WITH EPILEPSY: A RANDOMIZED CONTROLLED TRIAL. CONTEXT: MAJORITY OF EPILEPSY BEGINS IN CHILDHOOD. TWENTY TO THIRTY PERCENT OF PATIENTS MAY NOT RESPOND TO ANTIEPILEPTIC DRUGS. YOGA AS A COMPLEMENTARY THERAPY HAS BEEN FOUND TO BE BENEFICIAL IN ADULTS, BUT HAS NOT YET BEEN STUDIED IN CHILDREN WITH EPILEPSY. AIM: TO STUDY THE EFFECT OF YOGA ON SEIZURE AND ELECTROENCEPHALOGRAM (EEG) OUTCOME IN CHILDREN WITH EPILEPSY. SETTING AND DESIGN: A RANDOMIZED CONTROLLED TRIAL WAS CONDUCTED IN THE PEDIATRIC NEUROLOGY OUTPATIENT DEPARTMENT OF A TERTIARY CARE TEACHING HOSPITAL. MATERIALS AND METHODS: TWENTY CHILDREN AGED 8-12 YEARS WITH AN UNEQUIVOCAL DIAGNOSIS OF EPILEPSY ON REGULAR ANTIEPILEPTIC DRUGS WERE ENROLLED. YOGA THERAPY WAS PROVIDED TO 10 CHILDREN (STUDY GROUP) AND 10 CHILDREN FORMED THE CONTROL GROUP. YOGA THERAPY WAS GIVEN AS 10 SESSIONS OF 1H EACH. WE COMPARED SEIZURE FREQUENCY AND EEG AT BASELINE, 3, AND 6 MONTHS. STATISTICAL ANALYSIS WAS CARRIED OUT USING STANDARD STATISTICAL TESTS. A P VALUE OF <0.05 WAS CONSIDERED SIGNIFICANT. RESULTS: NO CHILDREN HAD SEIZURES AT THE END OF 3 AND 6 MONTHS IN THE STUDY GROUP. IN THE CONTROL GROUP, AT 3 AND 6 MONTHS, FOUR AND THREE CHILDREN, RESPECTIVELY, HAD SEIZURES. EIGHT CHILDREN EACH IN BOTH THE GROUPS HAD AN ABNORMAL EEG AT ENROLLMENT. AT THE END OF 6 MONTHS, ONE EEG IN THE STUDY GROUP AND SEVEN IN THE CONTROL GROUP WERE ABNORMAL (P = 0.020). CONCLUSION: YOGA AS AN ADDITIONAL THERAPY IN CHILDREN WITH EPILEPSY LEADS TO SEIZURE FREEDOM AND SIGNIFICANT IMPROVEMENT IN EEG AT 6 MONTHS. 2018 5 426 16 CAN YOGA BE USED TO TREAT GASTROESOPHAGEAL REFLUX DISEASE? YOGA METHODS INCLUDING PRANAYAMA ARE THE BEST WAYS TO PREVENT MANY DISEASES AND THEIR PROGRESSION. EVEN THOUGH, YOGA IS WIDELY PRACTICED, ITS EFFECTS ON CERTAIN MEDICAL CONDITIONS HAVE NOT BEEN STUDIED OR REPORTED. GASTROESOPHAGEAL REFLUX DISEASE (GERD) IS ONE OF THEM. GERD IS EXTREMELY COMMON CONDITION REQUIRING FREQUENT CONSUMPTION OF OVER-THE-COUNTER OR PRESCRIBED PROTON PUMP INHIBITORS (PPI). IN SEVERE SYMPTOMS OF GERD AND IN THE PRESENCE OF MULTIPLE ETIOLOGIES, PPIS ARE INSUFFICIENT TO RELIEVE THE SYMPTOMS OF GASTRIC REFLUX. REGULAR AND PROPER USE OF THE YOGA ALONG WITH PPI CAN CONTROL THE SEVERE SYMPTOMS OF GERD AND CAN AVOID OR DELAY THE NECESSITY OF INVASIVE PROCEDURES. THIS EVIDENCE-BASED CASE REPORT FOCUSES ON THE EFFECTS OF YOGA ON GERD. OUR CASE REPORT SHOWED THAT REGULAR PRACTICE OF KAPALBHATI AND AGNISAR KRIYA ALONG WITH PPI, PATIENTS WITH HIATAL HERNIA HAD IMPROVEMENT IN SEVERE SYMPTOMS OF GERD, WHICH WERE INITIALLY REFRACTORY TO PPI ALONE. 2013 6 2571 55 YOGA FOR EPILEPSY. BACKGROUND: THIS IS AN UPDATED VERSION OF THE ORIGINAL COCHRANE REVIEW PUBLISHED IN THE COCHRANE LIBRARY, ISSUE 1, 2002.YOGA MAY INDUCE RELAXATION AND STRESS REDUCTION, AND INFLUENCE THE ELECTROENCEPHALOGRAM AND THE AUTONOMIC NERVOUS SYSTEM, THEREBY CONTROLLING SEIZURES. YOGA WOULD BE AN ATTRACTIVE THERAPEUTIC OPTION FOR EPILEPSY IF PROVED EFFECTIVE. OBJECTIVES: TO ASSESS WHETHER PEOPLE WITH EPILEPSY TREATED WITH YOGA:(A) HAVE A GREATER PROBABILITY OF BECOMING SEIZURE FREE;(B) HAVE A SIGNIFICANT REDUCTION IN THE FREQUENCY OR DURATION OF SEIZURES, OR BOTH; AND(C) HAVE A BETTER QUALITY OF LIFE. SEARCH METHODS: WE SEARCHED THE COCHRANE EPILEPSY GROUP SPECIALIZED REGISTER (26 MARCH 2015), THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL, THE COCHRANE LIBRARY, 26 MARCH 2015), MEDLINE (OVID, 1946 TO 26 MARCH 2015), SCOPUS (1823 TO 9 JANUARY 2014), CLINICALTRIALS.GOV (26 MARCH 2015), THE WORLD HEALTH ORGANIZATION (WHO) INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM ICTRP (26 MARCH 2015), AND ALSO REGISTRIES OF THE YOGA BIOMEDICAL TRUST AND THE RESEARCH COUNCIL FOR COMPLEMENTARY MEDICINE. IN ADDITION, WE SEARCHED THE REFERENCES OF ALL THE IDENTIFIED STUDIES. NO LANGUAGE RESTRICTIONS WERE IMPOSED. SELECTION CRITERIA: THE FOLLOWING STUDY DESIGNS WERE ELIGIBLE FOR INCLUSION: RANDOMISED CONTROLLED TRIALS (RCT) OF TREATMENT OF EPILEPSY WITH YOGA. ELIGIBLE PARTICIPANTS WERE ADULTS WITH UNCONTROLLED EPILEPSY COMPARING YOGA WITH NO TREATMENT OR DIFFERENT BEHAVIOURAL TREATMENTS. DATA COLLECTION AND ANALYSIS: THREE REVIEW AUTHORS INDEPENDENTLY SELECTED TRIALS FOR INCLUSION AND EXTRACTED DATA. THE FOLLOWING OUTCOMES WERE ASSESSED: (A) PERCENTAGE OF PEOPLE RENDERED SEIZURE FREE; (B) SEIZURE FREQUENCY AND DURATION; (C) QUALITY OF LIFE. ANALYSES WERE ON AN INTENTION-TO-TREAT BASIS. ODDS RATIO (OR) WITH 95% CONFIDENCE INTERVALS (95% CL) WERE ESTIMATED FOR THE OUTCOMES. MAIN RESULTS: TWO UNBLINDED TRIALS RECRUITED A TOTAL OF 50 PEOPLE (18 TREATED WITH YOGA AND 32 TO CONTROL INTERVENTIONS). ANTIEPILEPTIC DRUGS WERE CONTINUED IN ALL THE PARTICIPANTS. BASELINE PHASE LASTED 3 MONTHS IN BOTH STUDIES AND TREATMENT PHASE FROM 5 WEEKS TO 6 MONTHS IN THE TWO TRIALS. RANDOMISATION WAS BY ROLL OF A DIE IN ONE STUDY AND USING A COMPUTERISED RANDOMISATION TABLE IN THE OTHER ONE BUT NEITHER STUDY PROVIDED DETAILS OF CONCEALMENT OF ALLOCATION AND WERE RATED AS UNCLEAR RISK OF BIAS. OVERALL, THE TWO STUDIES WERE RATED AS LOW RISK OF BIAS (ALL PARTICIPANTS WERE INCLUDED IN THE ANALYSIS; ALL EXPECTED AND PRE-EXPECTED OUTCOMES WERE REPORTED; NO OTHER SOURCES OF BIAS). THE OVERALL OR WITH 95% CONFIDENCE INTERVAL (CI) WAS: (I) SEIZURE FREE FOR SIX MONTHS - FOR YOGA VERSUS SHAM YOGA ORS OF 14.54 (95% CI 0.67 TO 316.69) AND FOR YOGA VERSUS NO TREATMENT GROUP 17.31 (95% CI 0.80 TO 373.45); FOR ACCEPTANCE AND COMMITMENT THERAPY (ACT) VERSUS YOGA ORS OF 1.00 (95% CL 0.16 TO 6.42; (II) REDUCTION IN SEIZURE FREQUENCY - THE MEAN DIFFERENCE BETWEEN YOGA VERSUS SHAM YOGA GROUP WAS -2.10 (95% CI -3.15 TO -1.05) AND FOR YOGA VERSUS NO TREATMENT GROUP -1.10 (95% CI -1.80 TO -0.40); (III) MORE THAN 50% REDUCTION IN SEIZURE FREQUENCY - FOR YOGA VERSUS SHAM YOGA GROUP ORS OF 81.00 (95% CI 4.36 TO 1504.46) AND FOR THE YOGA VERSUS NO TREATMENT GROUP 158.33 (95% CI 5.78 TO 4335.63); ACT VERSUS YOGA ORS OF 0.78 (95% CL 0.04 TO 14.75); (IV) MORE THAN 50% REDUCTION IN SEIZURE DURATION - FOR YOGA VERSUS SHAM YOGA GROUP ORS OF 45.00 (95% CI 2.01 TO 1006.75) AND FOR YOGA VERSUS NO TREATMENT GROUP 53.57 (95% CI 2.42 TO 1187.26); ACT VERSUS YOGA ORS OF 0.67 (95% CL 0.10 TO 4.35). IN ADDITION IN PANJWANI 1996 THE AUTHORS REPORTED THAT THE ONE-WAY ANALYSIS OF VARIANCE REVEALED NO STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE THREE GROUPS. A P-LAMBDA TEST TAKING INTO ACCOUNT THE P VALUES BETWEEN THE THREE GROUPS ALSO INDICATED THAT THE DURATION OF EPILEPSY IN THE THREE GROUPS WAS NOT COMPARABLE. NO DATA WERE AVAILABLE REGARDING QUALITY OF LIFE. IN LUNDGREN 2008 THE AUTHORS REPORTED THAT THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE YOGA AND ACT GROUPS IN SEIZURE FREE RATES, 50% OR GREATER REDUCTION IN SEIZURE FREQUENCY OR SEIZURE DURATION AT ONE YEAR FOLLOW-UP. THE YOGA GROUP SHOWED SIGNIFICANT IMPROVEMENT IN THEIR QUALITY OF LIFE ACCORDING TO THE SATISFACTION WITH LIFE SCALE (SWLS) (P < 0.05), WHILE THE ACT GROUP HAD SIGNIFICANT IMPROVEMENT IN THE WORLD HEALTH ORGANIZATION QUALITY OF LIFE-BREF (WHOQOL-BREF) SCALE (P < 0.01). AUTHORS' CONCLUSIONS: STUDY OF 50 SUBJECTS WITH EPILEPSY FROM TWO TRIALS REVEALS POSSIBLE BENEFICIAL EFFECT IN CONTROL OF SEIZURES. RESULTS OF THE OVERALL EFFICACY ANALYSIS SHOW THAT YOGA TREATMENT WAS BETTER WHEN COMPARED WITH NO INTERVENTION OR INTERVENTIONS OTHER THAN YOGA (POSTURAL EXERCISES MIMICKING YOGA). THERE WAS NO DIFFERENCE BETWEEN YOGA AND ACCEPTANCE AND COMMITMENT THERAPY. HOWEVER NO RELIABLE CONCLUSIONS CAN BE DRAWN REGARDING THE EFFICACY OF YOGA AS A TREATMENT FOR UNCONTROLLED EPILEPSY, IN VIEW OF METHODOLOGICAL DEFICIENCIES SUCH AS LIMITED NUMBER OF STUDIES, LIMITED NUMBER OF PARTICIPANTS RANDOMISED TO YOGA, LACK OF BLINDING AND LIMITED DATA ON QUALITY-OF-LIFE OUTCOME. PHYSICIAN BLINDING WOULD NORMALLY BE TAKEN TO BE THE PERSON DELIVERING THE INTERVENTION, WHEREAS WE THINK THE 'PHYSICIAN' WOULD IN FACT BE THE OUTCOME ASSESSOR (WHO COULD BE BLINDED), SO THAT WOULD BE A REDUCTION IN DETECTION BIAS RATHER THAN PERFORMANCE BIAS. IN ADDITION, EVIDENCE TO INFORM OUTCOMES IS LIMITED AND OF LOW QUALITY. FURTHER HIGH-QUALITY RESEARCH IS NEEDED TO FULLY EVALUATE THE EFFICACY OF YOGA FOR REFRACTORY EPILEPSY. 2015 7 2441 37 YOGA AND SCHIZOPHRENIA-A COMPREHENSIVE ASSESSMENT OF NEUROPLASTICITY: PROTOCOL FOR A SINGLE BLIND RANDOMIZED CONTROLLED STUDY OF YOGA IN SCHIZOPHRENIA. INTRODUCTION: SCHIZOPHRENIA IS ONE OF THE MOST SEVERE MENTAL DISORDERS WITH A PREVALENCE OF ABOUT 1% AND A LEADING CAUSE OF DISABILITY AMONG YOUNG ADULTS. PHARMACOTHERAPY IS THE MAINSTAY IN THE MANAGEMENT OF SCHIZOPHRENIA. HOWEVER, EVEN WITH THE BEST OF MEDICATION, SEVERAL PROBLEMS LIKE REFRACTORINESS, NEGATIVE SYMPTOMS, FREQUENT RELAPSES, AND COGNITIVE IMPAIRMENTS PERSIST. METHODS: THIS IS A RANDOMIZED-CONTROLLED CLINICAL STUDY INCLUDING PATIENTS FROM AN URBAN TERTIARY HOSPITAL AND A SEMI-URBAN COMMUNITY CENTER, WITH A BETWEEN-GROUP, REPEATED-MEASURES, LONGITUDINAL DESIGN. THIS STUDY WILL RECRUIT 160 PATIENTS WITH DSM 5 DIAGNOSIS OF SCHIZOPHRENIA WHO ARE ON STABLE MEDICATION FOR A MINIMUM OF 6 WEEKS; THEY WILL BE RANDOMLY ASSIGNED INTO 2 ARMS VIZ., YOGA THERAPY (YT), AND TREATMENT-AS-USUAL (TAU) WITH 80 PATIENTS IN EACH ARM. PARTICIPANTS WILL UNDERGO CLINICAL, LABORATORY, AND RADIOLOGICAL ASSESSMENTS AT BASELINE AND AT INTERVALS OF 1 MONTH, 3 MONTHS, AND 6 MONTHS FROM THE BASELINE. IT IS HYPOTHESIZED THAT YOGA WILL IMPROVE PSYCHOPATHOLOGY AND EMOTION PROCESSING, INCREASE SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND PLASMA OXYTOCIN LEVELS AND EFFECT CHANGES IN CEREBRAL ACTIVATION IN AREAS OF THE BRAIN ASSOCIATED WITH SCHIZOPHRENIA. DISCUSSION: THIS STUDY AIMS TO MEASURE THE EFFICACY OF A YOGA-BASED INTERVENTION AS AN ADJUNCT IN PATIENTS WITH SCHIZOPHRENIA AS WELL AS THE MECHANISMS OF THESE EFFECTS. TRIAL REGISTRATION: REGISTERED RETROSPECTIVELY WITH CLINICAL TRIAL REGISTRY - INDIA (CTRI) WITH REGISTRATION NUMBER CTRI/2017/08/009219. 2019 8 1865 38 RANDOMIZED PILOT TRIAL OF YOGA VERSUS STRENGTHENING EXERCISES IN BREAST CANCER SURVIVORS WITH CANCER-RELATED FATIGUE. PURPOSE: FATIGUE IS ONE OF THE MOST COMMON AND BOTHERSOME REFRACTORY SYMPTOMS EXPERIENCED BY CANCER SURVIVORS. MINDFUL EXERCISE INTERVENTIONS SUCH AS YOGA IMPROVE CANCER-RELATED FATIGUE; HOWEVER, STUDIES OF YOGA HAVE INCLUDED HETEROGENEOUS SURVIVORSHIP POPULATIONS, AND THE EFFECT OF YOGA ON FATIGUED SURVIVORS REMAINS UNCLEAR. METHODS: WE RANDOMLY ASSIGNED 34 EARLY-STAGE BREAST CANCER SURVIVORS WITH CANCER-RELATED FATIGUE (>/=4 ON A LIKERT SCALE FROM 1-10) WITHIN 1 YEAR FROM DIAGNOSIS TO A 12-WEEK INTERVENTION OF HOME-BASED YOGA VERSUS STRENGTHENING EXERCISES, BOTH PRESENTED ON A DVD. THE PRIMARY ENDPOINTS WERE FEASIBILITY AND CHANGES IN FATIGUE, AS MEASURED BY THE MULTIDIMENSIONAL FATIGUE SYMPTOM INVENTORY-SHORT FORM (MFSI-SF). SECONDARY ENDPOINT WAS QUALITY OF LIFE, ASSESSED BY THE FUNCTIONAL ASSESSMENT OF CANCER THERAPIES-BREAST (FACT-B). RESULTS: WE INVITED 401 WOMEN TO PARTICIPATE IN THE STUDY; 78 RESPONDED, AND WE ENROLLED 34. BOTH GROUPS HAD SIGNIFICANT WITHIN-GROUP IMPROVEMENT IN MULTIPLE DOMAINS OF THE FATIGUE AND QUALITY OF LIFE SCORES FROM BASELINE TO POST-INTERVENTION, AND THESE BENEFITS WERE MAINTAINED AT 3 MONTHS POST-INTERVENTION. HOWEVER, THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN GROUPS IN FATIGUE OR QUALITY OF LIFE AT ANY ASSESSMENT TIME. SIMILARLY, THERE WAS NO DIFFERENCE BETWEEN GROUPS IN ADHERENCE TO THE EXERCISE INTERVENTION. CONCLUSIONS: BOTH DVD-BASED YOGA AND STRENGTHENING EXERCISES DESIGNED FOR CANCER SURVIVORS MAY BE GOOD OPTIONS TO ADDRESS FATIGUE IN BREAST CANCER SURVIVORS. BOTH HAVE REASONABLE UPTAKE, ARE CONVENIENT AND REPRODUCIBLE, AND MAY BE HELPFUL IN DECREASING FATIGUE AND IMPROVING QUALITY OF LIFE IN THE FIRST YEAR POST-DIAGNOSIS IN BREAST CANCER PATIENTS WITH CANCER-RELATED FATIGUE. 2016 9 2782 36 YOGA THERAPY AS AN ADD-ON TREATMENT IN THE MANAGEMENT OF PATIENTS WITH SCHIZOPHRENIA--A RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TREATMENT OF SCHIZOPHRENIA HAS REMAINED UNSATISFACTORY DESPITE THE AVAILABILITY OF ANTIPSYCHOTICS. THIS STUDY EXAMINED THE EFFICACY OF YOGA THERAPY (YT) AS AN ADD-ON TREATMENT TO THE ONGOING ANTIPSYCHOTIC TREATMENT. METHOD: SIXTY-ONE MODERATELY ILL SCHIZOPHRENIA PATIENTS WERE RANDOMLY ASSIGNED TO YT (N = 31) AND PHYSICAL EXERCISE THERAPY (PT; N = 30) FOR 4 MONTHS. THEY WERE ASSESSED AT BASELINE AND 4 MONTHS AFTER THE START OF INTERVENTION, BY A RATER WHO WAS BLIND TO THEIR GROUP STATUS. RESULTS: FORTY-ONE SUBJECTS (YT = 21; PT = 20) WERE AVAILABLE AT THE END OF 4 MONTHS FOR ASSESSMENT. SUBJECTS IN THE YT GROUP HAD SIGNIFICANTLY LESS PSYCHOPATHOLOGY THAN THOSE IN THE PT GROUP AT THE END OF 4 MONTHS. THEY ALSO HAD SIGNIFICANTLY GREATER SOCIAL AND OCCUPATIONAL FUNCTIONING AND QUALITY OF LIFE. CONCLUSION: BOTH NON-PHARMACOLOGICAL INTERVENTIONS CONTRIBUTE TO REDUCTION IN SYMPTOMS, WITH YT HAVING BETTER EFFICACY. 2007 10 875 33 EFFECT OF YOGA THERAPY ON PLASMA OXYTOCIN AND FACIAL EMOTION RECOGNITION DEFICITS IN PATIENTS OF SCHIZOPHRENIA. CONTEXT: YOGA THERAPY HAS BEEN DEMONSTRATED TO BE USEFUL IN TREATMENT OF NEGATIVE SYMPTOMS AND IMPROVING THE SOCIO-OCCUPATIONAL FUNCTIONING AND EMOTION RECOGNITION DEFICITS IN ANTIPSYCHOTIC-STABILIZED SCHIZOPHRENIA PATIENTS. OXYTOCIN HAS BEEN RECENTLY IMPLICATED IN SOCIAL COGNITION DEFICITS IN SCHIZOPHRENIA. THE EFFECT OF YOGA THERAPY ON OXYTOCIN LEVELS IN SCHIZOPHRENIA HAS NOT BEEN STUDIED. AIMS: THIS STUDY AIMED TO ASSESS THE EFFECT OF YOGA THERAPY ON SYMPTOMS, SOCIO-OCCUPATIONAL FUNCTIONING, FACIAL EMOTION RECOGNITION DEFICITS AND PLASMA OXYTOCIN LEVELS IN ANTIPSYCHOTIC STABILIZED SCHIZOPHRENIA PATIENTS. SETTINGS AND DESIGN: RANDOMIZED CONTROLLED STUDY ON 43 CONSENTING, MEDICATION STABILIZED PATIENTS WITH SCHIZOPHRENIA IN A TERTIARY PSYCHIATRIC CENTER USING YOGA INTERVENTION AND WAITLISTED GROUPS. MATERIALS AND METHODS: A TOTAL OF 43 SCHIZOPHRENIA PATIENTS WERE RANDOMIZED TO YOGA GROUP (N=15) OR WAITLIST GROUP (N=28). PATIENTS IN THE YOGA GROUP RECEIVED TRAINING IN A SPECIFIC YOGA THERAPY MODULE FOR SCHIZOPHRENIA. PATIENTS IN BOTH GROUPS WERE CONTINUED ON STABLE ANTIPSYCHOTIC MEDICATION. ASSESSMENTS INCLUDED SCALE FOR ASSESSMENT OF POSITIVE SYMPTOMS, SCALE FOR ASSESSMENT OF NEGATIVE SYMPTOMS, SOCIO-OCCUPATIONAL FUNCTIONING SCALE AND TOOL FOR RECOGNITION OF EMOTIONS IN NEUROPSYCHIATRIC DISORDERS (TRENDS) AND PLASMA OXYTOCIN LEVELS; PERFORMED AT BASELINE AND AT THE END OF 1 MONTH. RESULTS: A TOTAL OF 15 PATIENTS IN THE YOGA GROUP AND 12 IN WAITLIST GROUP COMPLETED THE STUDY. THE YOGA THERAPY GROUP SHOWED A SIGNIFICANT IMPROVEMENT IN SOCIO-OCCUPATIONAL FUNCTIONING, PERFORMANCE ON TRENDS (P<0.001) AND PLASMA INCREASE IN OXYTOCIN LEVELS (P=0.01) AS COMPARED WITH THE WAITLIST GROUP. CONCLUSION: THE STUDY SUPPORTED THE ROLE OF ADD-ON YOGA THERAPY IN MANAGEMENT OF SCHIZOPHRENIA AND DEMONSTRATED AN IMPROVEMENT IN ENDOGENOUS PLASMA OXYTOCIN LEVELS IN SCHIZOPHRENIA PATIENTS RECEIVING YOGA THERAPY. 2013 11 2293 41 THERAPEUTIC EFFICACY OF ADD-ON YOGASANA INTERVENTION IN STABILIZED OUTPATIENT SCHIZOPHRENIA: RANDOMIZED CONTROLLED COMPARISON WITH EXERCISE AND WAITLIST. BACKGROUND: SCHIZOPHRENIA IS A HIGHLY DISABLING ILLNESS. PREVIOUS STUDIES HAVE SHOWN YOGA TO BE A FEASIBLE ADD-ON THERAPY IN SCHIZOPHRENIA. AIMS: THE CURRENT STUDY AIMED TO TEST THE EFFICACY OF YOGA AS AN ADD-ON TREATMENT IN OUTPATIENTS WITH SCHIZOPHRENIA. SETTINGS AND DESIGN: THE STUDY DONE AT A TERTIARY PSYCHIATRY CENTER USED A SINGLE BLIND RANDOMIZED CONTROLLED DESIGN WITH ACTIVE CONTROL AND WAITLIST GROUPS. MATERIALS AND METHODS: CONSENTING PATIENTS WITH SCHIZOPHRENIA WERE RANDOMIZED INTO YOGA, EXERCISE, OR WAITLIST GROUP. THEY CONTINUED TO RECEIVE PHARMACOLOGICAL THERAPY THAT WAS UNCHANGED DURING THE STUDY. PATIENTS IN THE YOGA OR EXERCISE GROUP WERE OFFERED SUPERVISED DAILY PROCEDURES FOR ONE MONTH. ALL PATIENTS WERE ASSESSED BY A BLIND RATER AT THE START OF THE INTERVENTION AND AT THE END OF 4 MONTHS. RESULTS: KENDALL TAU, A NONPARAMETRIC STATISTICAL TEST, SHOWED THAT SIGNIFICANTLY MORE PATIENTS IN THE YOGA GROUP IMPROVED IN POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) NEGATIVE AND TOTAL PANSS SCORES AS WELL AS SOCIAL FUNCTIONING SCORES COMPARED WITH THE EXERCISE AND WAITLIST GROUP. ODDS RATIO ANALYSIS SHOWED THAT THE LIKELIHOOD OF IMPROVEMENT IN YOGA GROUP IN TERMS OF NEGATIVE SYMPTOMS WAS ABOUT FIVE TIMES GREATER THAN EITHER THE EXERCISE OR WAITLIST GROUPS. CONCLUSION: IN SCHIZOPHRENIA PATIENTS WITH SEVERAL YEARS OF ILLNESS AND ON STABILIZED PHARMACOLOGICAL THERAPY, ONE-MONTH TRAINING FOLLOWED BY THREE MONTHS OF HOME PRACTICES OF YOGA AS AN ADD-ON TREATMENT OFFERED SIGNIFICANT ADVANTAGE OVER EXERCISE OR TREATMENT AS USUAL. YOGA HOLDS PROMISE AS A COMPLEMENTARY INTERVENTION IN THE MANAGEMENT OF SCHIZOPHRENIA. 2012 12 779 44 EFFECT OF YOGA AS ADD-ON THERAPY IN MIGRAINE (CONTAIN): A RANDOMIZED CLINICAL TRIAL. OBJECTIVE: TO EVALUATE THE EFFECTIVENESS OF YOGA AS AN ADJUVANT TO CONVENTIONAL MEDICAL MANAGEMENT ON CLINICAL OUTCOMES IN PATIENTS WITH MIGRAINE. METHODS: CONTAIN WAS A PROSPECTIVE, RANDOMIZED, OPEN-LABEL SUPERIORITY TRIAL WITH BLINDED ENDPOINT ASSESSMENT CARRIED OUT AT A SINGLE TERTIARY CARE ACADEMIC HOSPITAL IN NEW DELHI, INDIA. PATIENTS ENROLLED WERE AGED 18-50 YEARS WITH A DIAGNOSIS OF EPISODIC MIGRAINE AND WERE RANDOMIZED INTO MEDICAL AND YOGA GROUPS (1:1). RANDOMIZATION WAS COMPUTER-GENERATED WITH A VARIABLE BLOCK SIZE AND CONCEALED. A PREDESIGNED YOGA INTERVENTION WAS GIVEN FOR 3 MONTHS. OUTCOMES WERE RECORDED BY A BLINDED ASSESSOR. THE PRIMARY ENDPOINT WAS A DECREASE IN HEADACHE FREQUENCY, HEADACHE INTENSITY, AND HEADACHE IMPACT TEST (HIT)-6 SCORE. SECONDARY OUTCOMES INCLUDED CHANGE IN MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORE, PILL COUNT, AND PROPORTION OF HEADACHE FREE PATIENTS. RESULTS: BETWEEN APRIL 2017 AND AUGUST 2018, 160 PATIENTS WITH EPISODIC MIGRAINE WERE RANDOMLY ASSIGNED TO MEDICAL AND YOGA GROUPS. A TOTAL OF 114 PATIENTS COMPLETED THE TRIAL. BASELINE MEASURES WERE COMPARABLE EXCEPT FOR A HIGHER MEAN HEADACHE FREQUENCY IN THE YOGA GROUP. COMPARED TO MEDICAL THERAPY, THE YOGA GROUP SHOWED A SIGNIFICANT MEAN DELTA VALUE REDUCTION IN HEADACHE FREQUENCY (DELTA DIFFERENCE 3.53 [95% CONFIDENCE INTERVAL 2.52-4.54]; P < 0.0001), HEADACHE INTENSITY (1.31 [0.60-2.01]; P = 0.0004), HIT SCORE (8.0 [4.78-11.22]; P < 0.0001), MIDAS SCORE (7.85 [4.98-10.97]; P < 0.0001), AND PILL COUNT (2.28 [1.06-3.51]; P < 0.0003). CONCLUSION: YOGA AS AN ADD-ON THERAPY IN MIGRAINE IS SUPERIOR TO MEDICAL THERAPY ALONE. IT MAY BE USEFUL TO INTEGRATE A COST-EFFECTIVE AND SAFE INTERVENTION LIKE YOGA INTO THE MANAGEMENT OF MIGRAINE. CLINICALTRIALSGOV IDENTIFIER: CTRI/2017/03/008041. CLASSIFICATION OF EVIDENCE: THIS STUDY PROVIDES CLASS III EVIDENCE THAT FOR PATIENTS WITH EPISODIC MIGRAINE, YOGA AS ADJUVANT TO MEDICAL THERAPY IMPROVES HEADACHE FREQUENCY, INTENSITY, IMPACT, AND DISABILITY. 2020 13 1252 36 FEASIBILITY, ACCEPTABILITY AND EVALUATION OF MEDITATION TO AUGMENT YOGA PRACTICE AMONG PERSONS DIAGNOSED WITH SCHIZOPHRENIA. OBJECTIVE: TO DESIGN A MEDITATION PROTOCOL AND TEST ITS FEASIBILITY, ACCEPTABILITY AND EFFICACY IN CONJUNCTION WITH YT FOR PERSONS WITH SCHIZOPHRENIA (SZ). METHODS: THE MEDITATION PROTOCOL CONSISTED OF ANAPANA (OBSERVING NORMAL RESPIRATION) AND YOGA NIDRA (SUPINE, RESTFUL AWARENESS). IN A SINGLE BLIND RANDOMIZED CONTROLLED TRIAL, MEDICATED AND CLINICALLY STABLE OUTPATIENTS DIAGNOSED WITH SZ WERE RANDOMIZED TO RECEIVE TREATMENT AS USUAL (TAU), TAU AUGMENTED WITH YOGA TRAINING (YT), OR TAU AUGMENTED WITH MEDITATION AND YOGA TRAINING (MYT) FOR THREE WEEKS (N=145). ACCEPTABILITY, CLINICAL, SOCIAL AND COGNITIVE FUNCTIONS WERE ASSESSED AFTER 3 WEEKS AND 3 MONTHS POST RANDOMIZATION USING WITHIN GROUP AND BETWEEN GROUPS ANALYSES WITH REPEATED MEASURES MULTIVARIATE TESTS. RESULTS: NO GROUP-WISE DIFFERENCES IN COMPLIANCE, STUDY DISCONTINUATION, MAJOR/SERIOUS SIDE EFFECTS OR ADVERSE EVENTS WERE NOTED. FOR SIX ASSESSED CLINICAL VARIABLES, THE DIRECTION OF CHANGES WERE IN THE DESIRED DIRECTION AND THE EFFECT SIZES WERE GREATER IN THE MYT GROUP COMPARED WITH THE TAU GROUP AT BOTH TIME POINTS. CHANGES IN SOCIAL FUNCTION VARIABLES WERE GREATER AT 3 MONTHS THAN AT 3 WEEKS. NOMINALLY SIGNIFICANT IMPROVEMENT IN INDIVIDUAL COGNITIVE DOMAINS WERE NOTED IN ALL GROUPS AT BOTH TIME POINTS. ALL EFFECT SIZES WERE IN THE SMALL TO MEDIUM RANGE. CONCLUSION: MYT IS FEASIBLE, ACCEPTABLE AND SHOWS MODEST BENEFITS FOR PERSONS WITH SZ. MYT CAN ALSO IMPROVE QUALITY OF LIFE AND CLINICAL SYMPTOMS. LARGER STUDIES OF LONGER DURATION ARE WARRANTED. 2022 14 1413 28 IMPLEMENTING YOGA INTO THE MANAGEMENT OF PATIENTS WITH REFRACTORY LOW BACK PAIN IN AN OUTPATIENT CLINIC SETTING. PURPOSE: TO EVALUATE THE EFFECTIVENESS OF IMPLEMENTING YOGA INTO THE TREATMENT OF PATIENTS WITH CHRONIC LOW BACK PAIN. DESIGN: QUANTITATIVE ANALYSIS WITH OPPORTUNITY FOR QUALITATIVE FEEDBACK. METHOD: EFFECTIVENESS OF THIS COMPLEMENTARY TREATMENT WAS ASSESSED USING A PRETEST/POSTTEST DESIGN OF PATIENTS WHO VOLUNTEERED TO PARTICIPATE IN YOGA CLASSES AS PART OF THEIR BACK PAIN MANAGEMENT. MEASUREMENTS INCLUDED LOW BACK PAIN RATING, PERCEPTION OF BACK PAIN INTERFERENCE WITH DAILY ACTIVITIES, AND SELF-EFFICACY IN DEALING WITH CHRONIC LOW BACK PAIN. FINDINGS: ALTHOUGH NO STATISTICALLY SIGNIFICANT FINDINGS WERE FOUND DUE TO THE SMALL SAMPLE SIZE, MOST PARTICIPANTS DEMONSTRATED IMPROVED INDIVIDUAL SCORES ON ALL MEASUREMENT SURVEYS INCLUDING QUALITATIVE COMMENTS. CONCLUSION: BASED ON THE FINDINGS OF THIS PILOT STUDY, FURTHER STUDIES ON IMPLEMENTING YOGA INTO THE TREATMENT OF CHRONIC LOW BACK PAIN ARE ENCOURAGED. 2019 15 831 32 EFFECT OF YOGA ON MIGRAINE: A COMPREHENSIVE STUDY USING CLINICAL PROFILE AND CARDIAC AUTONOMIC FUNCTIONS. CONTEXT AND AIMS: MIGRAINE IS AN EPISODIC DISABLING HEADACHE REQUIRING LONG-TERM MANAGEMENT. MIGRAINE MANAGEMENT THROUGH YOGA THERAPY WOULD REDUCE THE MEDICATION COST WITH POSITIVE HEALTH BENEFITS. YOGA HAS SHOWN TO IMPROVE THE QUALITY OF LIFE, REDUCE THE EPISODE OF HEADACHE AND MEDICATION. THE AIM OF THE PRESENT STUDY WAS TO EVALUATE THE EFFICACY OF YOGA AS AN ADJUVANT THERAPY IN MIGRAINE PATIENTS BY ASSESSING CLINICAL OUTCOME AND AUTONOMIC FUNCTIONS TESTS. SUBJECTS AND METHODS: MIGRAINE PATIENTS WERE RANDOMLY GIVEN EITHER CONVENTIONAL CARE (N = 30) OR YOGA WITH CONVENTIONAL CARE (N = 30). YOGA GROUP RECEIVED YOGA PRACTICE SESSION FOR 5 DAYS A WEEK FOR 6 WEEKS ALONG WITH CONVENTIONAL CARE. CLINICAL ASSESSMENT (FREQUENCY, INTENSITY OF HEADACHE AND HEADACHE IMPACT) AND AUTONOMIC FUNCTION TEST WERE DONE AT BASELINE AND AT THE END OF THE INTERVENTION. RESULTS: YOGA WITH CONVENTIONAL CARE AND CONVENTION CARE GROUPS SHOWED SIGNIFICANT IMPROVEMENT IN CLINICAL VARIABLES, BUT IT WAS BETTER WITH YOGA THERAPY. IMPROVEMENT IN THE VAGAL TONE ALONG WITH REDUCED SYMPATHETIC ACTIVITY WAS OBSERVED IN PATIENTS WITH MIGRAINE RECEIVING YOGA AS ADJUVANT THERAPY. CONCLUSIONS: INTERVENTION SHOWED SIGNIFICANT CLINICAL IMPROVEMENT IN BOTH GROUPS. HEADACHE FREQUENCY AND INTENSITY WERE REDUCED MORE IN YOGA WITH CONVENTIONAL CARE THAN THE CONVENTIONAL CARE GROUP ALONE. FURTHERMORE, YOGA THERAPY ENHANCED THE VAGAL TONE AND DECREASED THE SYMPATHETIC DRIVE, HENCE IMPROVING THE CARDIAC AUTONOMIC BALANCE. THUS, YOGA THERAPY CAN BE EFFECTIVELY INCORPORATED AS AN ADJUVANT THERAPY IN MIGRAINE PATIENTS. 2014 16 161 32 A RANDOMISED CONTROLLED TRIAL OF ADJUNCTIVE YOGA AND ADJUNCTIVE PHYSICAL EXERCISE TRAINING FOR COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA. BACKGROUND: YOGA AND PHYSICAL EXERCISE HAVE BEEN USED AS ADJUNCTIVE INTERVENTION FOR COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA (SZ), BUT CONTROLLED COMPARISONS ARE LACKING. AIMS A SINGLE-BLIND RANDOMISED CONTROLLED TRIAL WAS DESIGNED TO EVALUATE WHETHER YOGA TRAINING OR PHYSICAL EXERCISE TRAINING ENHANCE COGNITIVE FUNCTIONS IN SZ, BASED ON A PRIOR PILOT STUDY. METHODS: CONSENTING, CLINICALLY STABLE, ADULT OUTPATIENTS WITH SZ (N=286) COMPLETED BASELINE ASSESSMENTS AND WERE RANDOMISED TO TREATMENT AS USUAL (TAU), SUPERVISED YOGA TRAINING WITH TAU (YT) OR SUPERVISED PHYSICAL EXERCISE TRAINING WITH TAU (PE). BASED ON THE PILOT STUDY, THE PRIMARY OUTCOME MEASURE WAS SPEED INDEX FOR THE COGNITIVE DOMAIN OF 'ATTENTION' IN THE PENN COMPUTERISED NEUROCOGNITIVE BATTERY. USING MIXED MODELS AND CONTRASTS, COGNITIVE FUNCTIONS AT BASELINE, 21 DAYS (END OF TRAINING), 3 AND 6 MONTHS POST-TRAINING WERE EVALUATED WITH INTENTION-TO-TREAT PARADIGM. RESULTS: SPEED INDEX OF ATTENTION DOMAIN IN THE YT GROUP SHOWED GREATER IMPROVEMENT THAN PE AT 6 MONTHS FOLLOW-UP (P<0.036, EFFECT SIZE 0.51). IN THE PE GROUP, 'ACCURACY INDEX OF ATTENTION DOMAIN SHOWED GREATER IMPROVEMENT THAN TAU ALONE AT 6-MONTH FOLLOW-UP (P<0.025, EFFECT SIZE 0.61). FOR SEVERAL OTHER COGNITIVE DOMAINS, SIGNIFICANT IMPROVEMENTS WERE OBSERVED WITH YT OR PE COMPARED WITH TAU ALONE (P<0.05, EFFECT SIZES 0.30-1.97). CONCLUSIONS: BOTH YT AND PE IMPROVED ATTENTION AND ADDITIONAL COGNITIVE DOMAINS WELL PAST THE TRAINING PERIOD, SUPPORTING OUR PRIOR REPORTED BENEFICIAL EFFECT OF YT ON SPEED INDEX OF ATTENTION DOMAIN. AS ADJUNCTS, YT OR PE CAN BENEFIT INDIVIDUALS WITH SZ. 2017 17 780 40 EFFECT OF YOGA AS AN ADD-ON THERAPY IN THE MODULATION OF HEART RATE VARIABILITY IN CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY. BACKGROUND: DUCHENE MUSCULAR DYSTROPHY (DMD) IS A PROGRESSIVE MUSCULAR DISORDER. CARDIAC DISORDER IS THE SECOND-MOST COMMON CAUSE OF DEATH IN CHILDREN WITH DMD, WITH 10%-20% OF THEM DYING OF CARDIAC FAILURE. HEART RATE VARIABILITY (HRV) IS SHOWN TO BE A PREDICTOR OF CARDIO-AUTONOMIC FUNCTION. PHYSIOTHERAPY (PT) IS ADVISED FOR THESE CHILDREN AS A REGULAR TREATMENT FOR MAINTAINING THEIR FUNCTIONAL STATUS. THE EFFECT OF YOGIC PRACTICES ON THE CARDIO-AUTONOMIC FUNCTIONS HAS BEEN DEMONSTRATED IN VARIOUS NEUROLOGICAL CONDITIONS AND MAY PROVE BENEFICIAL IN DMD. MATERIALS AND METHODS: IN THIS STUDY, 124 PATIENTS WITH DMD WERE RANDOMIZED TO PT ALONE OR PT WITH YOGA INTERVENTION. HOME-BASED PT AND YOGA WERE ADVISED. ADHERENCE WAS SERIALLY ASSESSED AT A FOLLOW-UP INTERVAL OF 3 MONTHS. ERROR-FREE, ELECTROCARDIOGRAM WAS RECORDED IN ALL PATIENTS AT REST IN THE SUPINE POSITION. HRV PARAMETERS WERE COMPUTED IN TIME AND FREQUENCY DOMAINS. HRV WAS RECORDED AT BASELINE AND AT AN INTERVAL OF 3 MONTHS UP TO 1 YEAR. REPEATED-MEASURES ANOVA WAS USED TO ANALYZE LONGITUDINAL FOLLOW-UP AND LEAST SIGNIFICANT DIFFERENCE FOR POST HOC ANALYSIS AND P < 0.05 WAS CONSIDERED STATISTICALLY SIGNIFICANT. RESULTS: IN OUR STUDY, WITH PT PROTOCOL, STANDARD DEVIATION OF NN, ROOT OF SQUARE MEAN OF SUCCESSIVE NN, TOTAL POWER, LOW FREQUENCY, HIGH-FREQUENCY NORMALIZED UNITS (HFNU), AND SYMPATHOVAGAL BALANCE IMPROVED AT VARYING TIME POINTS AND THE IMPROVEMENT LASTED UP FOR 6-9 MONTHS, WHEREAS PT AND YOGA PROTOCOL SHOWED AN IMPROVEMENT IN HFNU DURING THE LAST 3 MONTHS OF THE STUDY PERIOD AND ALL THE OTHER PARAMETERS WERE STABLE UP TO 1 YEAR. THUS, IT IS EVIDENT THAT BOTH THE GROUPS IMPROVED CARDIAC FUNCTIONS IN DMD. HOWEVER, NO SIGNIFICANT DIFFERENCE WAS NOTED IN THE CHANGES OBSERVED BETWEEN THE GROUPS. CONCLUSION: THE INTENSE PT AND PT WITH YOGA, PARTICULARLY HOME-BASED PROGRAM, IS INDEED BENEFICIAL AS A THERAPEUTIC STRATEGY IN DMD CHILDREN TO MAINTAIN AND/OR TO SUSTAIN HRV IN DMD. 2019 18 1863 30 RANDOMIZED CONTROLLED TRIAL OF YOGA AND EXERCISE IN MULTIPLE SCLEROSIS. OBJECTIVE: TO DETERMINE THE EFFECT OF YOGA AND OF AEROBIC EXERCISE ON COGNITIVE FUNCTION, FATIGUE, MOOD, AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS (MS). METHODS: SUBJECTS WITH CLINICALLY DEFINITE MS AND EXPANDED DISABILITY STATUS SCORE LESS THAN OR EQUAL TO 6.0 WERE RANDOMLY ASSIGNED TO ONE OF THREE GROUPS LASTING 6 MONTHS: WEEKLY IYENGAR YOGA CLASS ALONG WITH HOME PRACTICE, WEEKLY EXERCISE CLASS USING A STATIONARY BICYCLE ALONG WITH HOME EXERCISE, OR A WAITING-LIST CONTROL GROUP. OUTCOME ASSESSMENTS PERFORMED AT BASELINE AND AT THE END OF THE 6-MONTH PERIOD INCLUDED A BATTERY OF COGNITIVE MEASURES FOCUSED ON ATTENTION, PHYSIOLOGIC MEASURES OF ALERTNESS, PROFILE OF MOOD STATES, STATE-TRAIT ANXIETY INVENTORY, MULTI-DIMENSIONAL FATIGUE INVENTORY (MFI), AND SHORT FORM (SF)-36 HEALTH-RELATED QUALITY OF LIFE. RESULTS: SIXTY-NINE SUBJECTS WERE RECRUITED AND RANDOMIZED. TWELVE SUBJECTS DID NOT FINISH THE 6-MONTH INTERVENTION. THERE WERE NO ADVERSE EVENTS RELATED TO THE INTERVENTION. THERE WERE NO EFFECTS FROM EITHER OF THE ACTIVE INTERVENTIONS ON EITHER OF THE PRIMARY OUTCOME MEASURES OF ATTENTION OR ALERTNESS. BOTH ACTIVE INTERVENTIONS PRODUCED IMPROVEMENT IN SECONDARY MEASURES OF FATIGUE COMPARED TO THE CONTROL GROUP: ENERGY AND FATIGUE (VITALITY) ON THE SF-36 AND GENERAL FATIGUE ON THE MFI. THERE WERE NO CLEAR CHANGES IN MOOD RELATED TO YOGA OR EXERCISE. CONCLUSION: SUBJECTS WITH MS PARTICIPATING IN EITHER A 6-MONTH YOGA CLASS OR EXERCISE CLASS SHOWED SIGNIFICANT IMPROVEMENT IN MEASURES OF FATIGUE COMPARED TO A WAITING-LIST CONTROL GROUP. THERE WAS NO RELATIVE IMPROVEMENT OF COGNITIVE FUNCTION IN EITHER OF THE INTERVENTION GROUPS. 2004 19 353 33 ASSESSMENT OF THE QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA, BEFORE AND AFTER YOGA: A RANDOMISED TRIAL. YOGA WHICH IS USED AS AN ADJUNCT TREATMENT FOR BRONCHIAL ASTHMA IS GAINING POPULARITY THROUGHOUT THE WORLD. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFECT OF YOGA ON QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 120 NON-SMOKING MALE AND FEMALE PATIENTS OF ASTHMA IN THE AGE GROUP OF 17-50 YEARS WERE RANDOMIZED INTO TWO GROUPS I.E. GROUP A (YOGA GROUP) AND GROUP B (CONTROL GROUP). ALL PATIENTS REMAINED ON THEIR PRESCRIBED MEDICATION, BUT GROUP A PATIENTS PRACTICED YOGA BREATHING EXERCISES FOR 8 WEEKS. ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) AND DIARY RECORD WAS USED TO ASSESS QUALITY OF LIFE, NUMBER AND SEVERITY OF ASTHMATIC ATTACKS, AND THE DOSAGE OF THE MEDICATION REQUIRED AT BASELINE AND AFTER 8 WEEKS. GROUP A SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN "SYMPTOMS", "ACTIVITIES" AND "ENVIRONMENTAL" DOMAINS OF AQLQ AT 8 WEEKS (P<0.01) AND SIGNIFICANT REDUCTION IN DAILY NUMBER AND SEVERITY OF ATTACKS, AND THE DOSAGE OF MEDICATION REQUIRED AT 4 AND 8 WEEKS (P<0.01) COMPARED TO THE BASELINE. YOGA BREATHING EXERCISES USED ADJUNCTIVELY WITH STANDARD PHARMACOLOGICAL TREATMENT SIGNIFICANTLY IMPROVED QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 2014 20 288 28 ADJUNCTIVE COGNITIVE REMEDIATION FOR SCHIZOPHRENIA USING YOGA: AN OPEN, NON-RANDOMIZED TRIAL. BACKGROUND: YOGA THERAPY (YT) IMPROVES COGNITIVE FUNCTION IN HEALTHY INDIVIDUALS, BUT ITS IMPACT ON COGNITIVE FUNCTION AMONG PERSONS WITH SCHIZOPHRENIA (SZ) HAS NOT BEEN INVESTIGATED. AIMS: EVALUATE ADJUNCTIVE YT FOR COGNITIVE DOMAINS IMPAIRED IN SZ. METHODS: PATIENTS WITH SZ RECEIVED YT OR TREATMENT AS USUAL (TAU; N = 65, N = 23, RESPECTIVELY). ACCURACY AND SPEED FOR SEVEN COGNITIVE DOMAINS WERE ASSESSED USING A COMPUTERIZED NEUROCOGNITIVE BATTERY (CNB), THUS MINIMIZING OBSERVER BIAS. SEPARATELY, YT WAS EVALUATED AMONG PATIENTS WITH BIPOLAR I DISORDER (N = 40), MAJOR DEPRESSIVE DISORDER (N = 37), AND CARDIOLOGY OUTPATIENTS (N = 68). ALL PATIENTS ALSO RECEIVED ROUTINE PHARMACOTHERAPY. PATIENTS WERE NOT RANDOMIZED TO YT OR TAU. RESULTS: COMPARED WITH THE SZ/TAU GROUP, THE SZ/YT GROUP SHOWED SIGNIFICANTLY GREATER IMPROVEMENT WITH REGARD TO MEASURES OF ATTENTION FOLLOWING CORRECTIONS FOR MULTIPLE COMPARISONS; THE CHANGES WERE MORE PROMINENT AMONG THE MEN. IN THE OTHER DIAGNOSTIC GROUPS, DIFFERING PATTERNS OF IMPROVEMENTS WERE NOTED WITH SMALL TO MEDIUM EFFECT SIZES. CONCLUSIONS: OUR INITIAL ANALYSES SUGGEST NOMINALLY SIGNIFICANT IMPROVEMENT IN COGNITIVE FUNCTION IN SCHIZOPHRENIA WITH ADJUNCTIVE THERAPIES SUCH AS YT. THE MAGNITUDE OF THE CHANGE VARIES BY COGNITIVE DOMAIN AND MAY ALSO VARY BY DIAGNOSTIC GROUP. 2012